Axial Therapeutics announced that A. Stewart Campbell, Ph.D., chief executive officer, will participate in a panel titled “Placing Patients...

Axial Therapeutics announced that its scientific founder and California Institute of Technology (Caltech) Professor, Sarkis Mazmanian, Ph.D., will be...

Axial Therapeutics announced the publication of preclinical research demonstrating that microbial metabolites produced by gut bacteria commonly found in...

Axial Therapeutics announced the publication in Nature Medicine of full results from its Phase 1b/2a clinical trial of AB-2004....

Axial Therapeutics announced that management will participate in a fireside chat at the 2020 RBC Capital Markets Healthcare Private...

Axial Biotherapeutics announced a $440,000 grant from the Michael J. Fox Foundation for Parkinson’s Research to support its efforts...

Kairos Ventures portfolio company Axial Biotherapeutics announced the appointment of Dr. Gregory T. Bates as Senior Vice President of...

We're excited to share that our portfolio company, Axial Biotherapeutics, has been selected as one of FierceBiotech's Fierce 15...

This month, Axial Biotherapeutics announced the appointment of leading experts in the Autism Spectrum Disorders (ASD) field to its...